Financial reports
10-K
2023 FY
Annual report
9 Feb 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
10 Feb 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
10-Q
2022 Q1
Quarterly report
2 May 22
10-K
2021 FY
Annual report
22 Feb 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
Current reports
8-K
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
31 Jan 24
8-K
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
25 Jan 24
8-K
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
8 Jan 24
8-K
CVRx receives FDA approval for expanded labeling of Barostim
26 Dec 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
15 Dec 23
8-K
CVRx Reports Third Quarter 2023 Financial and Operating Results
26 Oct 23
8-K
CVRx Reports Second Quarter 2023 Financial and Operating Results
25 Jul 23
8-K
43rd Annual William Blair Growth Stock Conference, June 2023
8 Jun 23
8-K
CVRx Reports First Quarter 2023 Financial and Operating Results
27 Apr 23
8-K
Regulation FD Disclosure
21 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
9 Feb 24
S-8
Registration of securities for employees
9 Feb 24
S-8
Registration of securities for employees
10 Feb 23
424B5
Prospectus supplement for primary offering
15 Nov 22
S-3
Shelf registration
4 Nov 22
S-8
Registration of securities for employees
22 Feb 22
S-8
Registration of securities for employees
1 Jul 21
424B4
Prospectus supplement with pricing info
1 Jul 21
S-1MEF
Registration of additional securities for an S-1
29 Jun 21
8-A12B
Registration of securities on exchange
25 Jun 21
Other
SD
Conflict minerals disclosure
26 May 23
EFFECT
Notice of effectiveness
16 Nov 22
CORRESP
Correspondence with SEC
10 Nov 22
UPLOAD
Letter from SEC
10 Nov 22
EFFECT
Notice of effectiveness
30 Jun 21
CERT
Certification of approval for exchange listing
28 Jun 21
CORRESP
Correspondence with SEC
25 Jun 21
CORRESP
Correspondence with SEC
25 Jun 21
CORRESP
Correspondence with SEC
22 Jun 21
CORRESP
Correspondence with SEC
4 Jun 21
Ownership
4
Craig E. Palmer
27 Mar 24
4
& JOHNSON JOHNSON
6 Mar 24
4
PAUL VERRASTRO
27 Feb 24
4
PAUL VERRASTRO
22 Feb 24
144
Notice of proposed sale of securities
20 Feb 24
4
Kevin Hykes
14 Feb 24
SC 13G/A
Vensana Capital I GP, LLC
6 Feb 24
4
Craig E. Palmer
6 Feb 24
4
JARED OASHEIM
6 Feb 24
4
PAUL VERRASTRO
6 Feb 24